There might just be a potential cure for HIV! In a clinical trial an experimental antibody therapy reduced the amount of virus present in a human s blood. Researchers in a study conducted in Michel Nussenzweig's Laboratory of Molecular Immunology at Rockefeller University found that administration of a potent antibody called 3BNC117 can catch HIV off guard and reduce viral loads. HIV antibodies previously tested in humans had shown disappointing results. 3BNC117 belongs to a new generation of broadly neutralising antibodies that potently fight a wide range of HIV strains. Read about the 12 diseases that affect people with HIV/AIDS.